A detailed history of Creative Planning transactions in Dexcom Inc stock. As of the latest transaction made, Creative Planning holds 59,573 shares of DXCM stock, worth $4.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,573
Previous 48,693 22.34%
Holding current value
$4.78 Million
Previous $5.52 Million 27.68%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$64.0 - $116.06 $696,320 - $1.26 Million
10,880 Added 22.34%
59,573 $3.99 Million
Q2 2024

Aug 15, 2024

BUY
$110.31 - $140.45 $250,514 - $318,961
2,271 Added 4.89%
48,693 $5.52 Million
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $702,224 - $861,334
6,148 Added 15.27%
46,422 $6.44 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $182,383 - $299,970
2,416 Added 6.38%
40,274 $5 Million
Q3 2023

Nov 16, 2023

BUY
$86.06 - $137.93 $92,858 - $148,826
1,079 Added 2.93%
37,858 $3.53 Million
Q2 2023

Jul 21, 2023

BUY
$112.47 - $130.98 $247,883 - $288,679
2,204 Added 6.37%
36,779 $4.73 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $211,952 - $250,510
2,038 Added 6.26%
34,575 $4.02 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $335,840 - $484,791
3,952 Added 13.83%
32,537 $3.68 Million
Q3 2022

Nov 03, 2022

BUY
$76.35 - $94.18 $215,841 - $266,246
2,827 Added 10.98%
28,585 $2.3 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $1.34 Million - $2.62 Million
19,680 Added 323.79%
25,758 $1.92 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $101,041 - $139,834
1,074 Added 21.46%
6,078 $3.11 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $11,428 - $14,328
88 Added 1.79%
5,004 $2.69 Million
Q3 2021

Nov 10, 2021

SELL
$106.71 - $143.18 $89,956 - $120,700
-843 Reduced 14.64%
4,916 $2.69 Million
Q2 2021

Aug 04, 2021

BUY
$80.99 - $107.93 $34,096 - $45,438
421 Added 7.89%
5,759 $2.46 Million
Q1 2021

Apr 30, 2021

SELL
$84.79 - $104.74 $250,469 - $309,401
-2,954 Reduced 35.62%
5,338 $1.92 Million
Q4 2020

Jan 29, 2021

SELL
$78.0 - $104.5 $148,824 - $199,386
-1,908 Reduced 18.71%
8,292 $3.07 Million
Q3 2020

Nov 05, 2020

SELL
$95.51 - $112.95 $2,674 - $3,162
-28 Reduced 0.27%
10,200 $4.21 Million
Q2 2020

Jul 23, 2020

BUY
$62.68 - $105.34 $90,384 - $151,900
1,442 Added 16.41%
10,228 $4.15 Million
Q1 2020

May 05, 2020

BUY
$47.79 - $75.63 $25,328 - $40,083
530 Added 6.42%
8,786 $2.37 Million
Q4 2019

Jan 30, 2020

SELL
$36.62 - $57.29 $15,014 - $23,488
-410 Reduced 4.73%
8,256 $1.81 Million
Q3 2019

Nov 01, 2019

BUY
$35.53 - $43.8 $9,735 - $12,001
274 Added 3.27%
8,666 $1.29 Million
Q2 2019

Jul 26, 2019

SELL
$27.84 - $38.92 $57,183 - $79,941
-2,054 Reduced 19.66%
8,392 $1.26 Million
Q1 2019

Apr 24, 2019

BUY
$28.07 - $38.18 $14,371 - $19,548
512 Added 5.15%
10,446 $1.24 Million
Q4 2018

Feb 01, 2019

SELL
$26.99 - $37.37 $14,358 - $19,880
-532 Reduced 5.08%
9,934 $1.19 Million
Q3 2018

Oct 25, 2018

BUY
$23.35 - $36.72 $15,387 - $24,198
659 Added 6.72%
10,466 $1.5 Million
Q2 2018

Jul 20, 2018

SELL
$17.54 - $25.22 $6,226 - $8,953
-355 Reduced 3.49%
9,807 $931,000
Q1 2018

Apr 18, 2018

BUY
$13.06 - $18.54 $132,715 - $188,403
10,162 New
10,162 $754,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.